Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
diabetes
News
More Delays on MannKind's Inhaled Insulin: The Pros and Cons
BNET Pharma
Afrezza
diabetes
inhaled insulin
MannKind
»
4 comments
News
Bristol combination diabetes drug under review
Yahoo/AP
AstraZeneca
Bristol-Myers Squibb
diabetes
FDA
Onglyza
»
10 comments
News
FDA Says "No Way!" Market Says "Yeah, Baby!"(Byetta)
Motley Fool
Alkermes
Amylin
Byetta
diabetes
Eli Lilly
FDA
»
1 comment
News
Novartis Heart, Diabetes Drugs Fail to Prevent Disease in Study
Bloomberg
diabetes
Diovan
Novartis
»
1 comment
News
Amylin, Alkermes Gain as FDA Doesn’t Need More Byetta Data
Bloomberg
Alkermes
Amylin
Byetta
diabetes
FDA
»
2 comments
News
Studies: Intense treatment doesn't help diabetics
Yahoo/AP
Abbott Laboratories
diabetes
Lipitor
statins
Zocor
»
17 comments
News
Amylin shares fall ahead of diabetes drug decision
Yahoo/AP
Amylin
Byetta
diabetes
exanitide
FDA
»
1 comment
News
Transition Therapeutics and Lilly in diabetes deal
Yahoo/AP
diabetes
Eli Lilly
partnerships
Transition Therapeutics
»
9 comments
News
California County Sues Glaxo Over Avandia Risks
Pharmalot
Avandia
California
diabetes
GSK
lawsuits
»
2 comments
News
Diabetes Rivals Lick Chops Over Avandia Setback
Forbes
Avandia
diabetes
GSK
»
9 comments
« first
‹ previous
…
63
64
65
66
67
68
69
70
71
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT